Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents : A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial

NCT00947843 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT00947843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00947843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents : A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2013
Completion date
October 31, 2016
Enrollment
306 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease